Paper Details

  1. Home
  2. Paper Details

Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.

Author: EmamiZahra, KhamsehMohammad E, MaghsoomiZohreh, MalboosbafRamin, MalekMojtaba

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Peptide receptor radionuclide therapy (PRRT) is being investigated for the treatment of advanced thyroid cancer that is resistant to radioiodine therapy. This systematic review explores the efficacy and safety of PRRT for differentiated thyroid cancer (DTC) and medullary thyroid carcinoma (MTC) patients.
Paper Details　
Original Abstract of the Article :
It has been shown that a subgroup of patients with differentiated thyroid cancer (DTC) and medullary thyroid carcinoma (MTC) would progress to advanced stages of thyroid cancer. Therefore, the present study was done to systematically review available evidence in order to investigate efficacy and saf...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139052/

データ提供：米国国立医学図書館（NLM）

Peptide Receptor Radionuclide Therapy: A Potential Weapon Against Advanced Thyroid Cancer

Thyroid cancer, a type of cancer affecting the thyroid gland, can be difficult to treat, especially in advanced stages. This study examines the efficacy and safety of peptide receptor radionuclide therapy (PRRT) as a treatment option for patients with advanced, radioiodine-refractory differentiated thyroid cancer (RR-DTC) and metastatic medullary thyroid cancer (MTC). The study aims to provide a systematic review of available evidence on the use of PRRT in these specific patient groups.

PRRT: A Potential Treatment for Advanced Thyroid Cancer

The study's findings are yet to be published, but the systematic review aims to analyze the effectiveness and safety of PRRT in patients with advanced thyroid cancer. The researchers will examine a wide range of studies to assess the potential benefits and risks of PRRT, providing valuable insights into its potential role in treating these complex and challenging forms of thyroid cancer.

Navigating Thyroid Cancer Treatment: Understanding PRRT

This study highlights the potential of PRRT as a valuable treatment option for patients with advanced thyroid cancer. It underscores the importance of continued research into novel therapies for this challenging disease.

Dr.Camel's Conclusion

This research is like a desert explorer seeking a new path to fight against advanced thyroid cancer. The study examines PRRT, a promising treatment option, providing valuable insights into its potential benefits and risks.

Date :
  1. Date Completed 2021-10-18
  2. Date Revised 2021-10-18
Further Info :

Pubmed ID

34016077

DOI: Digital Object Identifier

PMC8139052

Related Literature

Article Analysis
・Side Effects of octreotide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.